For all the effort and investment drugs companies have put into improving business agility, the gap between vision and reality is glaring. This could be because companies have yet to transform R&D decision-making, says James Man, Kinapse.
Paras Kumar, senior specialist at The Smart Cube, examines the critical role that patent research has within the life sciences and pharmaceutical businesses beyond its traditional uses by the R&D and legal departments.
Neal Singh, COO of software company Icertis discusses how technology, in particular AI is helping to fast track drug discovery within research and development (R&D).
According to Frank Austin Nothaft, GTM lead for Genomics, Databricks, a unified approach to big data is the best way to get the most value. Here, he tells us more.
Here, Dr Natasha Varvogli, intellectual property consultant, and Maria Andrielou, marketing & communication at VIO Chemicals, look at patents and their role in the pharma industry.
Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence.
Bryan Plaster, VP Customer Services at Trifacta, tells us more about how establishing a centre of excellence (CoE) for data analytics can help organisations accelerate research & development (R&D).
In this article, Adrian Fellows, head of R&D at AGA Nanotech, looks at the current state of play in the global antimicrobial resistance crisis, revealing that we need solutions — like delivering high-energy oxidative molecules in a controlled manner
